April 2022 News & Views: Thank You for Joining Us for AMCP 2022; Register Today to Join Health Care Leaders in Addressing Health Disparities; AMCP Statement on the Introduction of the Access to Prescription Digital Therapeutics Act of 2022; Make an Impact at Nexus 2022 — Submit a Session Proposal or Poster Abstract; AMCP Names Mason Johnson 2022-2023 Executive Fellow in Health Care Association Leadership.
March 2022 News & Views: New AMCP CEO Blog: Get Inspired at AMCP 2022 in Chicago; Pharmacoequity: A New Opportunity for ManagedCare Pharmacy; Mark Your Calendar for the AMCP Health DisparitiesSummit on June 9; Explore Education Opportunities at AMCP 2022.
On April 27, AMCP joined a broad coalition of health care stakeholders in urging Congressional leaders to protect American's access to COVID-19 testing, treatments, and vaccines, regardless of insurance status - by replenishing the COVID-19 Uninsured Relief Fund.
Oncology is a specialization that involves the management of drug treatments for people with early and advanced cancers that affect the organs, muscles, bones and connective tissue. However, people with some early-stage cancers may be treated with surgery or radiation therapy alone and may not need the care of an oncologist.
On March 25, AMCP joined a diverse coalition of pharmacy stakeholders in expressing support for the Equitable Community Access for Pharmacists Services Act. This bill would permanently authorize pharmacists' ability to provide health care services during public health emergencies.
On April 19, AMCP joined a pharmacy stakeholder letter addressed to the Biden administration's COVID-19 czar, Dr. Ashish Jha. The letter urged the Biden administration to allow qualified pharmacists to prescribe oral antivirals to treat COVID-19 and maintain PREP Act services provided by pharmacists.